Home Other Building Blocks 98769-84-7
98769-84-7,MFCD11046031
Catalog No.:AA00IK3A

98769-84-7 | Reboxetine Mesylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$89.00   $62.00
- +
10mg
≥98%
in stock  
$149.00   $104.00
- +
100mg
97%
in stock  
$245.00   $172.00
- +
250mg
97%
in stock  
$488.00   $342.00
- +
1g
97%
in stock  
$1,218.00   $853.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00IK3A
Chemical Name:
Reboxetine Mesylate
CAS Number:
98769-84-7
Molecular Formula:
C20H27NO6S
Molecular Weight:
409.4965
MDL Number:
MFCD11046031
SMILES:
CS(=O)(=O)O.CCOc1ccccc1O[C@H](c1ccccc1)[C@@H]1OCCNC1
Properties
Computed Properties
 
Complexity:
425  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
6  

Literature

Title: Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.

Journal: Scientific reports 20160101

Title: Iodine-123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography.

Journal: Synapse (New York, N.Y.) 20121101

Title: Improved preclinical cardiovascular therapeutic indices with long-term inhibition of norepinephrine reuptake using reboxetine.

Journal: Toxicology and applied pharmacology 20121101

Title: Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20121001

Title: Acute antidepressant drug administration and autobiographical memory recall: a functional magnetic resonance imaging study.

Journal: Experimental and clinical psychopharmacology 20121001

Title: Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine.

Journal: Molecular and cellular biochemistry 20121001

Title: Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120901

Title: Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.

Journal: Neuropharmacology 20120901

Title: Reboxetine in clinical practice: a review.

Journal: La Clinica terapeutica 20120701

Title: Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120601

Title: Determination of reboxetine in rat brain microdialysates and plasma samples using liquid chromatography coupled to fluorescence detection.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120601

Title: Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.

Journal: Behavioural brain research 20120516

Title: Dopamine in the hippocampus is cleared by the norepinephrine transporter.

Journal: The international journal of neuropsychopharmacology 20120501

Title: Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases.

Journal: Journal of psychopharmacology (Oxford, England) 20120501

Title: Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.

Journal: Journal of psychopharmacology (Oxford, England) 20120501

Title: The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy.

Journal: Epilepsia 20120501

Title: Different involvement of ventral and dorsal norepinephrine pathways on norepinephrine reuptake inhibitor-induced locomotion and antidepressant-like effects in rats.

Journal: Neuroscience letters 20120418

Title: The declining use of reboxetine in years 2000 to 2006: a pharmacoepidemiological comparative study.

Journal: Journal of clinical psychopharmacology 20120401

Title: Morris water maze performance deficit produced by intermittent swim stress is partially mediated by norepinephrine.

Journal: Pharmacology, biochemistry, and behavior 20120301

Title: Severity of depression and response to antidepressants: GENPOD randomised controlled trial.

Journal: The British journal of psychiatry : the journal of mental science 20120201

Title: The noradrenaline reuptake inhibitor atomoxetine phase-shifts the circadian clock in mice.

Journal: Neuroscience 20120110

Title: Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks.

Journal: Psychopharmacology 20120101

Title: Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120101

Title: Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter.

Journal: Pharmacology, biochemistry, and behavior 20120101

Title: Citalopram versus other anti-depressive agents for depression.

Journal: The Cochrane database of systematic reviews 20120101

Title: In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.

Journal: Pharmacological reports : PR 20120101

Title: Second-generation antidepressants for seasonal affective disorder.

Journal: The Cochrane database of systematic reviews 20111207

Title: Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression.

Journal: Journal of sleep research 20111201

Title: Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.

Journal: Journal of affective disorders 20111101

Title: Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.

Journal: Journal of psychopharmacology (Oxford, England) 20111001

Title: Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus.

Journal: Psychological medicine 20111001

Title: Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.

Journal: Psychopharmacology 20111001

Title: Successful treatment of ultradian or ultra-ultra-rapid cycling: a case report.

Journal: Journal of affective disorders 20111001

Title: The memory function of noradrenergic activity in non-REM sleep.

Journal: Journal of cognitive neuroscience 20110901

Title: 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.

Journal: Neuropharmacology 20110901

Title: Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers.

Journal: NeuroImage 20110815

Title: The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ('ecstasy') in humans.

Journal: Clinical pharmacology and therapeutics 20110801

Title: A perhaps unexpected role of norepinephrine in actions of MDMA.

Journal: Clinical pharmacology and therapeutics 20110801

Title: ¹²³I-NKJ64: a novel single photon emission computed tomography radiotracer for imaging the noradrenaline transporter in brain.

Journal: Synapse (New York, N.Y.) 20110701

Title: Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.

Journal: The British journal of psychiatry : the journal of mental science 20110601

Title: Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110601

Title: The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients.

Journal: European archives of psychiatry and clinical neuroscience 20110401

Title: Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.

Journal: The international journal of neuropsychopharmacology 20110201

Title: Noradrenergic enhancement improves motor network connectivity in stroke patients.

Journal: Annals of neurology 20110201

Title: Novel antidepressants and panic disorder: evidence beyond current guidelines.

Journal: Neuropsychobiology 20110101

Title: Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus.

Journal: Neuropsychobiology 20110101

Title: Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.

Journal: European journal of pharmacology 20101125

Title: Reboxetine in depression. NICE guidance differs, so where next?

Journal: BMJ (Clinical research ed.) 20101116

Title: Reboxetine in depression. All the relevant data?

Journal: BMJ (Clinical research ed.) 20101116

Title: In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101101

Title: Natural killer cell cytotoxity and course of illness in depressed mood.

Journal: Psychiatria Danubina 20101101

Title: The effect of fluoxetine on electrical field stimulation-induced responses in the isolated rat small intestine.

Journal: Methods and findings in experimental and clinical pharmacology 20101101

Title: Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.

Journal: Human psychopharmacology 20101101

Title: Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study.

Journal: Attention deficit and hyperactivity disorders 20101101

Title: Finding studies on reboxetine: a tale of hide and seek.

Journal: BMJ (Clinical research ed.) 20101012

Title: Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.

Journal: British journal of pharmacology 20101001

Title: The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.

Journal: The Journal of pharmacology and experimental therapeutics 20100901

Title: Chiral separation by two-column, semi-continuous, open-loop simulated moving-bed chromatography.

Journal: Journal of chromatography. A 20100813

Title: Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study.

Journal: Journal of psychopharmacology (Oxford, England) 20100801

Title: Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons.

Journal: Journal of psychopharmacology (Oxford, England) 20100801

Title: Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100801

Title: From facial mimicry to emotional empathy: a role for norepinephrine?

Journal: Social neuroscience 20100801

Title: Co(III)(salen)-catalyzed HKR of two stereocentered alkoxy- and azido epoxides: a concise enantioselective synthesis of (S,S)-reboxetine and (+)-epi-cytoxazone.

Journal: Chemical communications (Cambridge, England) 20100721

Title: The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission.

Journal: Human psychopharmacology 20100701

Title: Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression.

Journal: Journal of psychiatry & neuroscience : JPN 20100701

Title: Alpha1-adrenoceptors modulate citalopram-induced serotonin release.

Journal: Neuropharmacology 20100601

Title: Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100601

Title: Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.

Journal: Brain, behavior, and immunity 20100501

Title: Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetine.

Journal: British journal of pharmacology 20100501

Title: Successful management of depression with reboxetine in a patient who developed Parkinsonism related to paroxetine use.

Journal: Journal of psychopharmacology (Oxford, England) 20100401

Title: Noradrenergic modulation of cortical networks engaged in visuomotor processing.

Journal: Cerebral cortex (New York, N.Y. : 1991) 20100401

Title: Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine.

Journal: Journal of clinical psychopharmacology 20100401

Title: Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.

Journal: Biological psychiatry 20100301

Title: Ambiguous-cue interpretation is biased under stress- and depression-like states in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100301

Title: A highly sensitive HPLC method with automated on-line sample pre-treatment and fluorescence detection for determination of reboxetine in human plasma.

Journal: Talanta 20100115

Title: Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100101

Title: Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

Journal: BMJ (Clinical research ed.) 20100101

Title: Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.

Journal: Neuro endocrinology letters 20100101

Title: The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.

Journal: Journal of affective disorders 20091101

Title: Running exercise-induced up-regulation of hippocampal brain-derived neurotrophic factor is CREB-dependent.

Journal: Hippocampus 20091001

Title: The antinociceptive properties of reboxetine in acute pain.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091001

Title: Effect of acute antidepressant administration on negative affective bias in depressed patients.

Journal: The American journal of psychiatry 20091001

Title: Rapid improvement in affective information processing after acute administration of reboxetine.

Journal: The American journal of psychiatry 20091001

Title: Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression.

Journal: Neuroscience letters 20090929

Title: Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.

Journal: Journal of psychopharmacology (Oxford, England) 20090901

Title: Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.

Journal: Bioorganic & medicinal chemistry letters 20090901

Title: Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.

Journal: Neuroscience research 20090701

Title: German agency refuses to rule on drug's benefits until Pfizer discloses all trial results.

Journal: BMJ (Clinical research ed.) 20090622

Title: Noradrenergic enhancement of amygdala responses to fear.

Journal: Social cognitive and affective neuroscience 20090601

Title: Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090501

Title: Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis.

Journal: Journal of psychiatric research 20090501

Title: Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test.

Journal: Life sciences 20090424

Title: Pharmacological REM sleep suppression paradoxically improves rather than impairs skill memory.

Journal: Nature neuroscience 20090401

Title: Noradrenergic stimulation and motor performance: differential effects of reboxetine on movement kinematics and visuomotor abilities in healthy human subjects.

Journal: Neuropsychologia 20090401

Title: The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20090317

Title: Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.

Journal: The international journal of neuropsychopharmacology 20090301

Title: Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study.

Journal: Psychopharmacology 20090301

Title: Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.

Journal: Neurobiology of disease 20090301

Title: 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.

Journal: Obesity (Silver Spring, Md.) 20090301

Title: The Valsalva maneuver: screening for drug-induced baroreflex dysfunction.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20090201

Title: Drugs under pressure: the Valsalva maneuver.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20090201

Title: Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.

Journal: Behavioural brain research 20090130

Title: Sensitive quantitation of reboxetine enantiomers in rat plasma and brain, using an optimised reverse phase chiral LC-MS/MS method.

Journal: Journal of pharmaceutical and biomedical analysis 20090115

Title: Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.

Journal: Journal of medicinal chemistry 20090108

Title: A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Title: Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Journal: European child & adolescent psychiatry 20090101

Title: Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants.

Journal: BMC neuroscience 20090101

Title: Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.

Journal: Clinical neuropharmacology 20090101

Title: Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Title: Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task.

Journal: Journal of biomedical science 20090101

Title: Reboxetine in therapy-resistant enuresis: a retrospective evaluation.

Journal: Scandinavian journal of urology and nephrology 20090101

Title: Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study.

Journal: The Israel journal of psychiatry and related sciences 20090101

Title: Potentiation of the antidepressant-like effect of desipramine or reboxetine by metyrapone in the forced swimming test in rats.

Journal: Pharmacological reports : PR 20090101

Title: The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.

Journal: European journal of pharmacology 20081228

Title: The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.

Journal: The Journal of clinical psychiatry 20081201

Title: Modeling a negative response bias in the human amygdala by noradrenergic-glucocorticoid interactions.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20081126

Title: Enantioseparation of the antidepressant reboxetine.

Journal: Journal of pharmaceutical and biomedical analysis 20081104

Title: The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study.

Journal: Molecular psychiatry 20081101

Title: Restless legs syndrome as side effect of second generation antidepressants.

Journal: Journal of psychiatric research 20081101

Title: Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.

Journal: Toxicology and applied pharmacology 20081101

Title: No influence of noradrenaline manipulation on acute exercise-induced increase of brain-derived neurotrophic factor.

Journal: Medicine and science in sports and exercise 20081101

Title: Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20081015

Title: Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.

Journal: Neuroscience 20081002

Title: Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.

Journal: Pharmacology, biochemistry, and behavior 20081001

Title: New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.

Journal: Bioorganic & medicinal chemistry letters 20080915

Title: Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry 20080801

Title: Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.

Journal: European journal of pharmacology 20080728

Title: The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous (mean HAM-D score) and dichotomous (response rate) outcomes.

Journal: The Kobe journal of medical sciences 20080718

Title: Stereoselective synthesis of (2S,3R)- and (2R,3S)-iodoreboxetine; potential SPECT imaging agents for the noradrenaline transporter.

Journal: Organic & biomolecular chemistry 20080707

Title: Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy.

Journal: Journal of psychopharmacology (Oxford, England) 20080701

Title: Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature.

Journal: Journal of applied physiology (Bethesda, Md. : 1985) 20080701

Title: Electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease.

Journal: The American journal of psychiatry 20080601

Title: Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20080515

Title: Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam.

Journal: Behavioural pharmacology 20080501

Title: Hormonal influences on cardiovascular norepinephrine transporter responses in healthy women.

Journal: Hypertension (Dallas, Tex. : 1979) 20080401

Title: An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder.

Journal: Journal of child and adolescent psychopharmacology 20080401

Title: Noradrenergic neuromodulation of human attention for emotional and neutral stimuli.

Journal: Psychopharmacology 20080301

Title: Norepinephrine transporter inhibition alters the hemodynamic response to hypergravitation.

Journal: Journal of applied physiology (Bethesda, Md. : 1985) 20080301

Title: A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080201

Title: Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.

Journal: Nuclear medicine and biology 20080201

Title: Syntheses of (S,S)-reboxetine via a catalytic stereospecific rearrangement of beta-amino alcohols.

Journal: The Journal of organic chemistry 20080118

Title: Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.

Journal: Bioorganic & medicinal chemistry 20080115

Title: Reversal of trichotillomania with aripiprazole.

Journal: Depression and anxiety 20080101

Title: [Toxicity in overdoses with new antidepressive agents. A survey of records shows different severity symptoms for different agents].

Journal: Lakartidningen 20080101

Title: Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells.

Journal: BMC neuroscience 20080101

Title: Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

Journal: Psychopharmacology 20071201

Title: Delivery outcome in relation to maternal use of some recently introduced antidepressants.

Journal: Journal of clinical psychopharmacology 20071201

Title: Reboxetine maintenance treatment in children with attention-deficit/hyperactivity disorder: a long-term follow-up study.

Journal: Journal of child and adolescent psychopharmacology 20071201

Title: Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.

Journal: The international journal of neuropsychopharmacology 20071001

Title: Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071001

Title: Emotion-induced retrograde amnesia varies as a function of noradrenergic-glucocorticoid activity.

Journal: Psychopharmacology 20071001

Title: Single dose antidepressant administration modulates the neural processing of self-referent personality trait words.

Journal: NeuroImage 20070901

Title: Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.

Journal: The Journal of clinical psychiatry 20070801

Title: Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus.

Journal: Neuropharmacology 20070701

Title: Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study.

Journal: Psychopharmacology 20070601

Title: Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.

Journal: Psychopharmacology 20070601

Title: Low serum concentrations of reboxetine in 2 patients treated with CYP3A4 inducers.

Journal: Journal of clinical psychopharmacology 20070601

Title: Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study.

Journal: The British journal of psychiatry : the journal of mental science 20070601

Title: In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter.

Journal: European journal of nuclear medicine and molecular imaging 20070501

Title: Increased fetal blood pressure response to maternal norepinephrine after pharmacological inhibition of norepinephrine uptake in pregnant sheep.

Journal: Acta paediatrica (Oslo, Norway : 1992) 20070501

Title: A quantitative application of the J-based configuration analysis method to a flexible small molecule.

Journal: Magnetic resonance in chemistry : MRC 20070401

Title: Motor cortex excitability after vagus nerve stimulation in major depression.

Journal: Journal of clinical psychopharmacology 20070401

Title: Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20070330

Title: Prediction of treatment response in major depression: integration of concepts.

Journal: Journal of affective disorders 20070301

Title: Inhibition of selective noradrenergic reuptake as treatment of pathological laughter.

Journal: Journal of clinical psychopharmacology 20070201

Title: Reboxetine improves motor function in chronic stroke. A pilot study.

Journal: Journal of neurology 20070201

Title: Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER.

Journal: Bioorganic & medicinal chemistry letters 20070115

Title: Reboxetine treatment and pseudopheochromocytoma.

Journal: QJM : monthly journal of the Association of Physicians 20070101

Title: Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans.

Journal: International journal of clinical pharmacology and therapeutics 20070101

Title: Reboxetine combination in treatment-resistant depression to selective serotonin reuptake inhibitors.

Journal: Pharmacopsychiatry 20070101

Title: Chronic dose effects of reboxetine on motor skill acquisition and cortical excitability.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20070101

Title: Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats.

Journal: Hippocampus 20070101

Title: Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.

Journal: Journal of child and adolescent psychopharmacology 20061201

Title: Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061101

Title: Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine.

Journal: Journal of affective disorders 20061001

Title: Monotherapy with reboxetine in amphetamine withdrawal syndrome.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20060930

Title: A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20060930

Title: Psychopharmacology of maternal separation anxiety in vervet monkeys.

Journal: Metabolic brain disease 20060901

Title: Noradrenaline might enhance assertive human social behaviours: an investigation in a flatmate relationship.

Journal: Pharmacopsychiatry 20060901

Title: Transfer of reboxetine into breastmilk, its plasma concentrations and lack of adverse effects in the breastfed infant.

Journal: European journal of clinical pharmacology 20060801

Title: No effects of enhanced central norepinephrine on finger-sequence learning and attention.

Journal: Psychopharmacology 20060801

Title: Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.

Journal: Journal of the American College of Cardiology 20060801

Title: The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Journal: Molecular psychiatry 20060701

Title: Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing.

Journal: European journal of pharmacology 20060701

Title: Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans.

Journal: Hypertension (Dallas, Tex. : 1979) 20060701

Title: Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.

Journal: Psychopharmacology 20060701

Title: Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.

Journal: Journal of neurochemistry 20060701

Title: Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.

Journal: Human psychopharmacology 20060701

Title: Depression in adults.

Journal: Clinical evidence 20060601

Title: Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

Journal: Pharmacology & therapeutics 20060501

Title: Asymptomatic reboxetine overdose.

Journal: The international journal of neuropsychopharmacology 20060401

Title: The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060401

Title: Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy.

Journal: Journal of affective disorders 20060401

Title: Does the clinical course of depression determine improvement in symptoms and quality of life?

Journal: The Journal of nervous and mental disease 20060401

Title: Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.

Journal: Journal of clinical psychopharmacology 20060401

Title: Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.

Journal: Journal of clinical psychopharmacology 20060401

Title: Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.

Journal: Molecular psychiatry 20060201

Title: Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.

Journal: The Journal of clinical psychiatry 20060201

Title: Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.

Journal: Journal of psychopharmacology (Oxford, England) 20060101

Title: Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex.

Journal: Journal of neurochemistry 20060101

Title: Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode.

Journal: General hospital psychiatry 20060101

Title: Reboxetine in therapy-resistant enuresis: results and pathogenetic implications.

Journal: Scandinavian journal of urology and nephrology 20060101

Title: Reboxetine addition in patients with mirtazapine-resistant depression: a case series.

Journal: Clinical neuropharmacology 20060101

Title: A highly sensitive spectrofluorometric method for the determination of a new antidepressant drug, reboxetine, in tablets.

Journal: Journal of AOAC International 20060101

Title: A selective high-performance liquid chromatography method for the determination of reboxetine in bulk drug and tablets.

Journal: Journal of AOAC International 20060101

Title: Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.

Journal: Advances in therapy 20060101

Title: Lack of hypo/hyperglycemic effects of reboxetine in diabetic and non-diabetic rats.

Journal: Fundamental & clinical pharmacology 20051201

Title: An open trial of reboxetine in obese patients with binge eating disorder.

Journal: Eating and weight disorders : EWD 20051201

Title: Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.

Journal: Psychopharmacology 20051101

Title: Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain.

Journal: Psychopharmacology 20051101

Title: Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.

Journal: The Journal of clinical psychiatry 20051101

Title: Profound weight loss associated with reboxetine use in a 44-year-old woman.

Journal: British journal of clinical pharmacology 20050801

Title: Noradrenergic modulation of emotion-induced forgetting and remembering.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050706

Title: Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.

Journal: Nuclear medicine and biology 20050701

Title: Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.

Journal: Journal of neurochemistry 20050701

Title: Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.

Journal: International journal of clinical pharmacology and therapeutics 20050701

Title: Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor?

Journal: Biological psychiatry 20050615

Title: Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050601

Title: Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.

Journal: Epilepsy research 20050601

Title: Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder.

Journal: Journal of the American Academy of Child and Adolescent Psychiatry 20050501

Title: Synthesis, enantiomeric resolution, F-18 labeling and biodistribution of reboxetine analogs: promising radioligands for imaging the norepinephrine transporter with positron emission tomography.

Journal: Nuclear medicine and biology 20050501

Title: The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression.

Journal: Pharmacopsychiatry 20050501

Title: Reboxetine for the treatment of patients with Cocaine Dependence Disorder.

Journal: Human psychopharmacology 20050401

Title: Reboxetine as an optional treatment for hyperkinetic conduct disorder: a prospective open-label trial.

Journal: Journal of child and adolescent psychopharmacology 20050401

Title: Asymmetric synthesis of (+)-(S,S)-reboxetine via a new (S)-2-(hydroxymethyl)morpholine preparation.

Journal: Organic letters 20050303

Title: The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment.

Journal: Psychopharmacology 20050301

Title: Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.

Journal: Journal of neurochemistry 20050301

Title: Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.

Journal: Chemical research in toxicology 20050301

Title: Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.

Journal: Psychopharmacology 20050201

Title: Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.

Journal: European journal of pain (London, England) 20050201

Title: Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity after surgery in rats.

Journal: Pain 20050201

Title: Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect.

Journal: Psychopharmacology 20050101

Title: Escitalopram/reboxetine combination in depressed patients with substance use disorder.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20050101

Title: Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practice.

Journal: CNS drugs 20050101

Title: Sex differences in cortisol response to reboxetine.

Journal: Journal of psychopharmacology (Oxford, England) 20050101

Title: Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.

Journal: Neuropsychobiology 20050101

Title: An evaluation of efficacy and safety of reboxetine in elderly patients affected by 'retarded' post-stroke depression. A random, placebo-controlled study.

Journal: Archives of gerontology and geriatrics 20050101

Title: A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.

Journal: Neuropsychobiology 20050101

Title: Lessons in conflict of interest: the construction of the martyrdom of David Healy and the dilemma of bioethics.

Journal: The American journal of bioethics : AJOB 20050101

Title: Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20050101

Title: Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain.

Journal: Psychosomatics 20050101

Title: Very early treatment with fluoxetine and reboxetine causing long-lasting change of the serotonin but not the noradrenaline transporter in the frontal cortex of rats.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20050101

Title: [Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder].

Journal: Turk psikiyatri dergisi = Turkish journal of psychiatry 20050101

Title: Effects of some new antidepressant drugs on the glucocorticoid receptor-mediated gene transcription in fibroblast cells.

Journal: Pharmacological reports : PR 20050101

Title: Worsening of borderline symptoms under reboxetine treatment.

Journal: The Journal of neuropsychiatry and clinical neurosciences 20050101

Title: Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041201

Title: Narcolepsy with cataplexy.

Journal: The American journal of psychiatry 20041201

Title: [Review of antidepressants from the TCAs to the third generation drugs].

Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201

Title: Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.

Journal: European psychiatry : the journal of the Association of European Psychiatrists 20041101

Title: Sleepwalking associated with reboxetine in a young female patient with major depression--a case report.

Journal: Pharmacopsychiatry 20041101

Title: Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation.

Journal: Neuroreport 20041025

Title: Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression.

Journal: Psychopharmacology 20041001

Title: Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.

Journal: European journal of pharmacology 20040919

Title: Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.

Journal: European journal of pharmacology 20040913

Title: [SSRI resistant depression. Supplementation with noradrenergic pharmaceuticals can be a good alternative].

Journal: Lakartidningen 20040902

Title: Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia.

Journal: Journal of psychopharmacology (Oxford, England) 20040901

Title: Use of reboxetine in bulimia nervosa: a pilot study.

Journal: Journal of psychopharmacology (Oxford, England) 20040901

Title: Reboxetine induces similar sleep-EEG changes like SSRI's in patients with depression.

Journal: Pharmacopsychiatry 20040901

Title: Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study.

Journal: Pharmacopsychiatry 20040901

Title: Adjunctive use of reboxetine in schizophrenia.

Journal: European psychiatry : the journal of the Association of European Psychiatrists 20040901

Title: Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.

Journal: The Journal of clinical psychiatry 20040901

Title: The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients.

Journal: Pharmacopsychiatry 20040901

Title: PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.

Journal: Synapse (New York, N.Y.) 20040801

Title: [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].

Journal: MMW Fortschritte der Medizin 20040708

Title: Reboxetine adjunct for partial or nonresponders to antidepressant treatment.

Journal: Journal of affective disorders 20040701

Title: Reboxetine may be helpful in the treatment of amphetamine withdrawal.

Journal: British journal of clinical pharmacology 20040701

Title: Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

Journal: The American journal of psychiatry 20040701

Title: Improved motor skill acquisition after selective stimulation of central norepinephrine.

Journal: Neurology 20040608

Title: Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study.

Journal: Journal of clinical psychopharmacology 20040601

Title: A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.

Journal: European psychiatry : the journal of the Association of European Psychiatrists 20040601

Title: Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20040525

Title: Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function.

Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20040501

Title: Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices.

Journal: Neuropharmacology 20040501

Title: Management of anorexia nervosa revisited: drug treatment suggestions are questionable.

Journal: BMJ (Clinical research ed.) 20040501

Title: Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats.

Journal: European journal of pharmacology 20040412

Title: Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

Journal: Psychopharmacology 20040401

Title: Effect of reboxetine on major depressive disorder in breast cancer patients: an open-label study.

Journal: The Journal of clinical psychiatry 20040401

Title: Chiral synthesis of (2S,3S)-2-(2-morpholin-2-yl-2-phenylmethoxy)phenol.

Journal: Chirality 20040301

Title: Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects.

Journal: Psychoneuroendocrinology 20040201

Title: Norepinephrine and pain.

Journal: Pain 20040201

Title: Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.

Journal: Journal of neurochemistry 20040201

Title: Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20040201

Title: Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects.

Journal: Neuroendocrinology 20040101

Title: The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.

Journal: CNS drug reviews 20040101

Title: Reboxetine: a norepinephrine selective reuptake pump inhibitor.

Journal: Journal of psychiatric practice 20040101

Title: Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs.

Journal: Synapse (New York, N.Y.) 20031215

Title: Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.

Journal: Journal of medicinal chemistry 20031204

Title: Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.

Journal: Epilepsy & behavior : E&B 20031201

Title: Specific modulation of sigma binding sites by the anxiolytic drug opipramol.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20031001

Title: Successful suppression of cataplectic attacks with tramadol.

Journal: Neurology 20030923

Title: Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of alpha 2 and 5-HT1A receptors.

Journal: Neuroscience letters 20030918

Title: Effects of reboxetine on sympathetic neuroeffector transmission in rabbit carotid artery.

Journal: The Journal of pharmacology and experimental therapeutics 20030901

Title: Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030901

Title: Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.

Journal: International clinical psychopharmacology 20030901

Title: Acute reboxetine administration increases plasma and salivary cortisol.

Journal: Journal of psychopharmacology (Oxford, England) 20030901

Title: Reboxetine in cocaine withdrawal treatment: a three cases report.

Journal: Drug and alcohol review 20030901

Title: Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine.

Journal: European journal of pharmacology 20030822

Title: Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine.

Journal: Journal of clinical psychopharmacology 20030801

Title: An open clinical trial of reboxetine in the treatment of social phobia.

Journal: Journal of clinical psychopharmacology 20030801

Title: Depersonalization-derealization syndrome induced by reboxetine.

Journal: Swiss medical weekly 20030712

Title: Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome).

Journal: European journal of clinical pharmacology 20030701

Title: Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition.

Journal: Circulation 20030617

Title: Hyponatremia associated with the initiation of reboxetine therapy.

Journal: European journal of clinical pharmacology 20030601

Title: Reboxetine promotes social bonding in healthy volunteers.

Journal: Journal of psychopharmacology (Oxford, England) 20030601

Title: [Reboxetine in the treatment of bulimia nervosa].

Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20030601

Title: The efficacy of reboxetine in preventing and reverting a condition of escape deficit in rats.

Journal: Biological psychiatry 20030515

Title: Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff's syndrome.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030501

Title: Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.

Journal: International clinical psychopharmacology 20030501

Title: Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.

Journal: The American journal of psychiatry 20030501

Title: Contrasting effects of citalopram and reboxetine on waking salivary cortisol.

Journal: Psychopharmacology 20030401

Title: Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetine.

Journal: Therapeutic drug monitoring 20030401

Title: An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder.

Journal: The Journal of clinical psychiatry 20030401

Title: Decision making in humans: the effect of manipulating the central noradrenergic system.

Journal: Journal of neurology, neurosurgery, and psychiatry 20030301

Title: The antidepressant efficacy of reboxetine in patients with severe depression.

Journal: Journal of clinical psychopharmacology 20030201

Title: Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.

Journal: The American journal of psychiatry 20030201

Title: Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod.

Journal: European journal of clinical pharmacology 20030201

Title: Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter.

Journal: Nuclear medicine and biology 20030201

Title: Norepinephrine-gamma-aminobutyric acid (GABA) interaction in limbic stress circuits: effects of reboxetine on GABAergic neurons.

Journal: Biological psychiatry 20030115

Title: Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.

Journal: Psychopharmacology 20030101

Title: Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.

Journal: International clinical psychopharmacology 20030101

Title: Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment.

Journal: Journal of psychiatric research 20030101

Title: [Combination therapy with reboxetine for major depression patients who are partial or nonresponders to serotonin selective reuptake inhibitors].

Journal: Actas espanolas de psiquiatria 20030101

Title: The promises and pitfalls of reboxetine.

Journal: CNS drug reviews 20030101

Title: Reboxetine: a novel antidepressant.

Journal: Journal of postgraduate medicine 20030101

Title: The effects of reboxetine, a noradrenaline reuptake inhibitor, on the plasma noradrenaline response to a cold pressor test in healthy volunteers.

Journal: Journal of psychopharmacology (Oxford, England) 20021201

Title: Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care.

Journal: Journal of psychopharmacology (Oxford, England) 20021201

Title: Reboxetine: attenuation of intravenous nicotine self-administration in rats.

Journal: The Journal of pharmacology and experimental therapeutics 20021101

Title: Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation.

Journal: Psychopharmacology 20021101

Title: Norepinephrine transporter function and autonomic control of metabolism.

Journal: The Journal of clinical endocrinology and metabolism 20021101

Title: Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021101

Title: Reboxetine: a preliminary report on its use through the Special Access Program.

Journal: Journal of psychiatry & neuroscience : JPN 20021101

Title: The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20021001

Title: The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study.

Journal: Human psychopharmacology 20021001

Title: Superior safety of reboxetine over amitryptiline in the elderly.

Journal: European journal of medical research 20020930

Title: Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine.

Journal: Neuroscience letters 20020927

Title: [New antidepressive drug with good tolerance. Patients function in daily life].

Journal: MMW Fortschritte der Medizin 20020919

Title: The effects of reboxetine on human sleep architecture in depression: preliminary results.

Journal: Journal of affective disorders 20020901

Title: Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: preliminary data.

Journal: Psychopharmacology 20020901

Title: Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.

Journal: The Journal of clinical psychiatry 20020901

Title: Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020801

Title: Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801

Title: Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors.

Journal: The Journal of pharmacology and experimental therapeutics 20020801

Title: Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials.

Journal: Journal of clinical psychopharmacology 20020801

Title: Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.

Journal: Journal of clinical psychopharmacology 20020801

Title: Combining antidepressants for treatment-resistant depression: a review.

Journal: The Journal of clinical psychiatry 20020801

Title: No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists.

Journal: Medicine and science in sports and exercise 20020701

Title: Separation of reboxetine enantiomers by means of capillary electrophoresis.

Journal: Electrophoresis 20020601

Title: Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain.

Journal: European journal of pharmacology 20020517

Title: SNRI and hyponatremia.

Journal: International journal of geriatric psychiatry 20020501

Title: Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020401

Title: Functional effects of agents differentially selective to noradrenergic or serotonergic systems.

Journal: Psychological medicine 20020401

Title: Effect of reboxetine on depression in Parkinson's disease patients.

Journal: The Journal of clinical psychiatry 20020401

Title: Determination of reboxetine, a recent antidepressant drug, in human plasma by means of two high-performance liquid chromatography methods.

Journal: Journal of chromatography. A 20020308

Title: Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression.

Journal: International clinical psychopharmacology 20020301

Title: Successful treatment of recurrent brief depression with reboxetine -- a single case analysis.

Journal: Pharmacopsychiatry 20020301

Title: Sexual dysfunction caused by reboxetine.

Journal: Pharmacopsychiatry 20020301

Title: Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatography.

Journal: Journal of chromatography. A 20020222

Title: Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.

Journal: European journal of pharmacology 20020202

Title: Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study.

Journal: Psychopharmacology 20020201

Title: [Analgesic effect of the selective noradrenaline reuptake inhibitor reboxetine].

Journal: Der Nervenarzt 20020201

Title: Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance.

Journal: Circulation 20020122

Title: Analysis of reboxetine, a novel antidepressant drug, in pharmaceutical tablets by capillary electrophoresis and derivative spectrophotometry.

Journal: Journal of pharmaceutical and biomedical analysis 20020101

Title: Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20020101

Title: Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.

Journal: The Journal of clinical psychiatry 20020101

Title: Difference in serotonergic and noradrenergic regulation of human social behaviours.

Journal: Psychopharmacology 20020101

Title: The effects of noradrenergic re-uptake inhibition on memory encoding in man.

Journal: Psychopharmacology 20020101

Title: Reboxetine for central pain: a single-blind prospective study.

Journal: Clinical neuropharmacology 20020101

Title: LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report.

Journal: The Israel journal of psychiatry and related sciences 20020101

Title: Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors.

Journal: Polish journal of pharmacology 20020101

Title: Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201

Title: No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites.

Journal: Therapeutic drug monitoring 20011201

Title: Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.

Journal: Psychopharmacology 20011101

Title: Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy.

Journal: International clinical psychopharmacology 20011101

Title: Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study.

Journal: International clinical psychopharmacology 20010901

Title: Lack of effect of reboxetine on cardiac repolarization.

Journal: Clinical pharmacology and therapeutics 20010901

Title: The effects of reboxetine on autonomic and cognitive functions in healthy volunteers.

Journal: Psychopharmacology 20010901

Title: S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

Journal: The Journal of pharmacology and experimental therapeutics 20010801

Title: S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

Journal: The Journal of pharmacology and experimental therapeutics 20010801

Title: Effects of noradrenergic activity on temporal information processing in humans.

Journal: The Quarterly journal of experimental psychology. B, Comparative and physiological psychology 20010801

Title: Reboxetine-induced hypomania.

Journal: The Journal of clinical psychiatry 20010801

Title: Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons.

Journal: The European journal of neuroscience 20010601

Title: Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.

Journal: The Journal of pharmacology and experimental therapeutics 20010501

Title: Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20010501

Title: Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study.

Journal: Sleep 20010501

Title: Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents.

Journal: Psychopharmacology 20010501

Title: The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.

Journal: Psychopharmacology 20010401

Title: Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases.

Journal: Neuropharmacology 20010301

Title: Modulation of MK-801-induced behaviour by noradrenergic agents in mice.

Journal: Psychopharmacology 20010301

Title: Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC.

Journal: Therapeutic drug monitoring 20010201

Title: Reboxetine in seasonal affective disorder: an open trial.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010201

Title: Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.

Journal: Psychopharmacology 20010201

Title: Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.

Journal: British journal of pharmacology 20010101

Title: Role of serotonin and noradrenaline in social dysfunction: a review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS).

Journal: General hospital psychiatry 20010101

Title: Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.

Journal: Journal of child and adolescent psychopharmacology 20010101

Title: Depression in Parkinson's disease. An update.

Journal: Advances in neurology 20010101

Title: Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?

Journal: Polish journal of pharmacology 20010101

Title: Effect of repeated treatment with reboxetine on the central alpha1-adrenergic system.

Journal: Polish journal of pharmacology 20010101

Title: Urinary retention with reboxetine-fluoxetine combination in a young man.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie 20001201

Title: Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.

Journal: Clinical pharmacokinetics 20001201

Title: Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

Journal: Biological psychiatry 20000501

Title: Reboxetine: the first selective noradrenaline re-uptake inhibitor.

Journal: Expert opinion on pharmacotherapy 20000501

Title: Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes.

Journal: Drug metabolism and disposition: the biological fate of chemicals 19991101

Title: Reversal of tetrabenazine induced depression by selective noradrenaline (norepinephrine) reuptake inhibition.

Journal: Journal of neurology, neurosurgery, and psychiatry 19991001

Title: Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.

Journal: Journal of affective disorders 19991001

Title: Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 19970401

Title: Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding.

Journal: Biopharmaceutics & drug disposition 19950801

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:98769-84-7 Molecular Formula|98769-84-7 MDL|98769-84-7 SMILES|98769-84-7 Reboxetine Mesylate